Apollon Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Apollon Wealth Management's GILD Position: Q2 2026 in Review
Apollon Wealth Management increased its Gilead Sciences (GILD) stake by 8.2% in Q2 2026, buying an estimated $384K and bringing the position to 38,585 shares worth $4.87M. The position accounts for 0.06% of the portfolio, ranked #270.
Apollon Wealth Management first reported a position in GILD in Q2 2020 and has held it in 23 quarters since. The position peaked at $4.97M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Apollon Wealth Management held 38,585 shares of Gilead Sciences worth $4.87M as of Q2 2026.
- Apollon Wealth Management bought 2,918 Gilead Sciences shares in Q2 2026, an estimated $384K.
- Gilead Sciences made up 0.06% of Apollon Wealth Management's portfolio in Q2 2026, its #270 holding.
- Apollon Wealth Management first reported a position in Gilead Sciences in Q2 2020 and has held it in 23 quarters since.
- Apollon Wealth Management's Gilead Sciences position peaked at $4.97M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.